Gating of Na channels. Inactivation modifiers discriminate among models.
Macroscopic Na currents were recorded from N18 neuroblastoma cells by the whole-cell voltage-clamp technique. Inactivation of the Na currents was removed by intracellular application of proteolytic enzymes, trypsin, alpha-chymotrypsin, papain, or ficin, or bath application of N-bromoacetamide. Unlike what has been reported in squid giant axons and frog skeletal muscle fibers, these treatments often increased Na currents at all test pulse potentials. In addition, removal of inactivation gating shifted the midpoint of the peak Na conductance-voltage curve in the negative direction by 26 mV on average and greatly prolonged the rising phase of Na currents for small depolarizations. Polypeptide toxins from Leiurus quinquestriatus scorpion and Goniopora coral, which slow inactivation in adult nerve and muscle cells, also increase the peak Na conductance and shift the peak conductance curve in the negative direction by 7-10 mV in neuroblastoma cells. Control experiments argue against ascribing the shifts to series resistance artifacts or to spontaneous changes of the voltage dependence of Na channel kinetics. The negative shift of the peak conductance curve, the increase of peak Na currents, and the prolongation of the rise at small depolarization after removal of inactivation are consistent with gating kinetic models for neuroblastoma cell Na channels, where inactivation follows nearly irreversible activation with a relatively high, voltage-independent rate constant and Na channels open only once in a depolarization. As the same kind of experiment does not give apparent shifting of activation and prolongation of the rising phase of Na currents in adult axon and muscle membranes, the Na channels of these other membranes probably open more than once in a depolarization.
D000081:Acetamides / Q000494:pharmacology; D000818:Animals; D002460:Cell Line; D005557:Formaldehyde / Q000494:pharmacology; D007473:Ion Channels / Q000502:physiology*; D008387:Marine Toxins / Q000494:pharmacology; D008954:Models, Biological; D009447:Neuroblastoma / Q000378:metabolism / Q000473:pathology; D010447:Peptide Hydrolases / Q000494:pharmacology; D010455:Peptides / Q000494:pharmacology; D012604:Scorpion Venoms / Q000494:pharmacology; D012964:Sodium / Q000378:metabolism*
D000081:Acetamides; D007473:Ion Channels; D008387:Marine Toxins; D010455:Peptides; D012604:Scorpion Venoms; C016272:N-bromoacetamide; D005557:Formaldehyde; D012964:Sodium; D010447:Peptide Hydrolases